The Japan Ministry of Health, Labor and Welfare granted approval to the Lonsurf combination tablet T15 and T20 (trifluridine and tipiracil hydrochloride), for the treatment of patients with unresectable advanced or recurrent colorectal cancer, if refractory to standard therapies.
The European Commission approved a subcutaneous formulation of MabThera (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma.
THE RESEARCH!AMERICA Advocacy Awards was held March 12 in Washington, D.C., recognizing individuals and organizations are those whose leadership efforts have been notably effective in advancing our nation's commitment to research.
THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO signed an agreement with Advaxis Inc. to evaluate several new immunotherapy constructs, each built on Advaxis proprietary technology.
THE AMERICAN SOCIETY OF HEMATOLOGY announced 15 research investigators who will receive critical interim support for hematology research proposals that, despite earning high scores, could not be funded by the NIH amid severe funding reductions.
ARTHUR CAPLAN received the 2014 Public Service Award from the National Science Board. Caplan is the founding head of the Division of Bioethics at New York University Langone Medical Center.
THE OHIO STATE UNIVERSITY signed a licensing agreement with MedVax Technologies Inc., for the licensing of cancer peptide vaccine technologies.
F. MARC STEWART was named incoming president of the board of directors of both the Patient Advocate Foundation and National Patient Advocate Foundation. Stewart has been a member of the foundation’s scientific board since 2003. Since 2000, he has been a professor of medical oncology at the University of Washington Medical School, medical director for... […]
KENNETH PIENTA was named director of the Prostate Cancer Program at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. He is joined by two co-directors, Samuel Denmeade and Shawn Lupold.
VICTOR FAZIO and HAGOP KANTARJIAN will each receive lifetime achievement awards from Castle Connolly Medical Ltd. during their National Physician of the Year Awards, scheduled March 31 in New York City.
